0001209191-23-017029.txt : 20230307 0001209191-23-017029.hdr.sgml : 20230307 20230307213239 ACCESSION NUMBER: 0001209191-23-017029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sutaria Saumya CENTRAL INDEX KEY: 0001760857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 23714732 MAIL ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-06 0 0000070318 TENET HEALTHCARE CORP THC 0001760857 Sutaria Saumya 14201 DALLAS PARKWAY DALLAS TX 75254 1 1 0 0 CEO Common Stock 2023-03-06 4 M 0 21065 A 344440 D Common Stock 2023-03-06 4 F 0 10445 60.62 D 333995 D Common Stock 2023-03-06 4 M 0 25229 A 359224 D Common Stock 2023-03-06 4 F 0 12509 59.29 D 346715 D Common Stock 2023-03-06 4 M 0 47962 A 394677 D Common Stock 2023-03-06 4 F 0 23780 59.29 D 370897 D Common Stock 2023-03-06 4 M 0 57449 A 428346 D Common Stock 2023-03-06 4 F 0 28510 59.29 D 399836 D 2022 February Restricted Stock Units 2023-03-06 4 M 0 21065 0.00 D Common Stock 21065 42131 D 2021 February Restricted Stock Units 2023-03-06 4 M 0 25229 0.00 D Common Stock 25229 25229 D 2020 February Restricted Stock Units 2023-03-06 4 M 0 47962 0.00 D Common Stock 47962 0 D 2020 February Performance-Based Restricted Stock Units 2023-03-06 4 M 0 57449 0.00 D Common Stock 57449 0 D The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. Restricted stock units convert into common stock on a one-for-one basis. The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. Represents the closing price of the common stock of the Issuer on the vesting date. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023. On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023. Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Chad J. Wiener, as Attorney-in-Fact for Saumya Sutaria 2023-03-07